Exploring Aehr Test Systems (AEHR) Investor Profile: Who’s Buying and Why?

Exploring Aehr Test Systems (AEHR) Investor Profile: Who’s Buying and Why?

US | Technology | Semiconductors | NASDAQ

Aehr Test Systems (AEHR) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Have you ever wondered who the key players are behind Aehr Test Systems (AEHR), and what motivates their investment decisions? As of April 2025, 274 institutional owners and shareholders have filed forms with the SEC, holding a total of 24,843,849 shares. With the share price experiencing a 25.23% decline from $10.82 on April 18, 2024, to $8.09 on April 17, 2025, understanding the investor landscape becomes crucial. Are these shifts influenced by the company's revenue, which reached $66.22 million in 2024, a 1.94% increase from the previous year, or perhaps by the impressive 127.77% surge in earnings to $33.16 million? Let's delve into the details to uncover who is investing in Aehr Test Systems and, more importantly, why.

Aehr Test Systems (AEHR) Who Invests in Aehr Test Systems (AEHR) and Why?

Understanding the investor profile of Aehr Test Systems (AEHR) provides valuable insights into market sentiment and the factors driving investment decisions. Examining the composition of AEHR's investor base, their motivations, and typical investment strategies can help current and prospective investors make informed choices. Here’s a detailed look into who invests in AEHR and why.

Key Investor Types:

The investor base of Aehr Test Systems (AEHR) comprises a mix of retail investors, institutional investors, and hedge funds. Each group has different investment horizons, risk tolerances, and objectives, influencing their investment decisions regarding AEHR.

  • Retail Investors: These individual investors often focus on growth opportunities and may be drawn to AEHR's potential in the semiconductor testing market.
  • Institutional Investors: These include mutual funds, pension funds, and insurance companies that typically hold larger positions and invest based on in-depth research and long-term growth prospects.
  • Hedge Funds: These are typically more active investors who may take both long and short positions, seeking to capitalize on short-term market movements and specific company events.

Investment Motivations:

Several factors attract investors to Aehr Test Systems (AEHR). These motivations often align with the company's growth prospects, market position, and technological advancements.

  • Growth Prospects: AEHR's growth potential in the silicon carbide (SiC) and other semiconductor testing markets is a significant draw. The increasing demand for SiC in electric vehicles and other high-growth applications positions AEHR favorably.
  • Market Position: AEHR's specialized test and burn-in systems cater to the advanced needs of semiconductor manufacturers, giving it a competitive edge in niche markets.

Investment Strategies:

The investment strategies employed by AEHR investors vary depending on their investment goals and risk appetite.

  • Long-Term Holding: Many institutional investors adopt a long-term holding strategy, banking on AEHR's sustained growth in the semiconductor testing market. This involves holding the stock for an extended period to benefit from the company's long-term value appreciation.
  • Short-Term Trading: Hedge funds and some retail investors may engage in short-term trading, capitalizing on stock price volatility and news-driven events.
  • Value Investing: Some investors may view AEHR as undervalued, considering its growth potential and market position. They adopt a value investing approach, purchasing the stock with the expectation that the market will eventually recognize its true worth.

Aehr Test Systems' investor profile is shaped by its unique position in the semiconductor testing industry. Investors are drawn to its growth prospects, technological advancements, and strategic market position. Understanding these factors provides valuable context for evaluating AEHR as an investment opportunity.

To gain further insights into Aehr Test Systems' financial health, consider exploring: Breaking Down Aehr Test Systems (AEHR) Financial Health: Key Insights for Investors

Aehr Test Systems (AEHR) Institutional Ownership and Major Shareholders of Aehr Test Systems (AEHR)

Institutional ownership in Aehr Test Systems (AEHR) provides insights into the company's stability and investor confidence. Examining which institutions hold significant stakes, the changes in their positions, and the overall impact they have can offer a clearer understanding of the stock's potential and the company's strategic direction.

As of the fiscal year 2024, several institutional investors have significant holdings in Aehr Test Systems (AEHR). While specific, up-to-the-minute data on institutional ownership can fluctuate, major institutional holders typically include investment management firms, hedge funds, and pension funds. These entities often make investment decisions based on extensive research and analysis, reflecting their long-term outlook on the company.

Changes in institutional ownership can signal shifts in sentiment towards Aehr Test Systems (AEHR). Increases in holdings may indicate positive expectations for future performance, driven by factors such as technological advancements, market expansion, or strong financial results. Conversely, decreases may suggest concerns about growth prospects, competitive pressures, or broader economic trends.

The influence of institutional investors on Aehr Test Systems (AEHR)'s stock price and strategy is substantial. Large institutional investors can drive trading volumes and impact stock valuation. Their investment decisions often influence market perception and can attract or deter other investors. Additionally, these major shareholders may engage with the company's management regarding strategic decisions, corporate governance, and overall performance, thereby playing a role in shaping the company's direction.

While specific data regarding the top institutional investors and their exact shareholdings in Aehr Test Systems (AEHR) varies and is subject to change, keeping an eye on these trends can provide valuable insights for current and prospective investors. Continuous monitoring of SEC filings and financial news is essential to stay informed about the latest shifts in institutional ownership and their potential implications for Aehr Test Systems (AEHR).

Here's a general overview of how institutional investors might interact with a company like Aehr Test Systems (AEHR):

  • Engagement with Management: Large institutional investors often communicate directly with the management team to discuss performance, strategy, and governance issues.
  • Voting Rights: Institutional investors exercise their voting rights on important matters such as board elections, executive compensation, and significant corporate actions.
  • Market Influence: Their trading activities can significantly influence the stock price, creating both opportunities and risks for other investors.

For more insights into Aehr Test Systems (AEHR), you might find this resource helpful: Aehr Test Systems (AEHR): History, Ownership, Mission, How It Works & Makes Money.

Aehr Test Systems (AEHR) Key Investors and Their Impact on Aehr Test Systems

Understanding the investor profile of Aehr Test Systems (AEHR) can provide valuable insights into the company's stability, growth potential, and strategic direction. A diverse mix of institutional, retail, and insider ownership characterizes the company’s shareholder base.

As of recent filings, 72% of Aehr Test Systems is held by institutional investors, indicating significant influence from these entities. This substantial institutional ownership suggests that the stock price may be sensitive to the trading actions of these major players. The top 11 shareholders collectively own 51% of the company, highlighting a concentration of influence among a select group of investors.

Here's a list of the top institutional shareholders in Aehr Test Systems (AEHR) and their holdings as of December 31, 2024:

  • FMR LLC: Holds 3.08 million shares, representing 10.34% of the company, valued at $25,815,452.
  • Vanguard Group Inc: Holds 2.18 million shares, representing 7.33% of the company, valued at $18,320,748.
  • BlackRock Inc: Holds 2.05 million shares, representing 6.87% of the company, valued at $17,171,008.
  • Baillie Gifford & Co: Holds 2.02 million shares, representing 6.80% of the company, valued at $16,977,660.
  • Ameriprise Financial, Inc: Holds 1.28 million shares, representing 4.30% of the company, valued at $10,746,373.
  • AWM Investment Company, Inc: Holds 1.24 million shares, representing 4.16% of the company, valued at $10,396,880.
  • Point72 Asset Management, L.P.: Holds 920.43k shares, representing 3.09% of the company, valued at $7,722,382.

Mutual funds also hold significant positions in Aehr Test Systems. Here are some of the top mutual fund holders:

  • Vanguard Total Stock Market Index Fund: Holds 860.41k shares, representing 2.89% of the company, valued at $7,218,831.
  • Columbia Small Cap Growth Fund: Holds 743.04k shares, representing 2.50% of the company, valued at $6,234,114.
  • iShares Russell 2000 ETF: Holds 718.32k shares, representing 2.41% of the company, valued at $6,026,713.

In Q4 2024, several institutional investors made notable changes to their positions in Aehr Test Systems:

  • POINT72 ASSET MANAGEMENT, L.P.: Increased its holdings by 920,427 shares (over +inf%), with an estimated value of $15,306,701.
  • FMR LLC: Increased its holdings by 457,823 shares (+17.5%), with an estimated value of $7,613,596.
  • BANK OF AMERICA CORP /DE/: Increased its holdings by 278,946 shares (+319.5%), with an estimated value of $4,638,871.
  • MARSHALL WACE, LLP: Reduced its holdings by 662,125 shares (-100.0%), with an estimated value of $11,011,138.
  • OBERWEIS ASSET MANAGEMENT INC/: Reduced its holdings by 534,400 shares (-100.0%), with an estimated value of $8,887,072.
  • ARDSLEY ADVISORY PARTNERS LP: Reduced its holdings by 270,000 shares (-100.0%), with an estimated value of $4,490,100.
  • DIKER MANAGEMENT LLC: Reduced its holdings by 250,000 shares (-100.0%), with an estimated value of $4,157,499.

These changes reflect varying sentiments among institutional investors, with some increasing their stakes significantly while others divested entirely.

Insiders hold approximately 6.48% of Aehr Test Systems' stock. Robert R. Anderson is the largest individual shareholder among the insiders, owning 1.08 million shares, which represents 3.63% of the company, valued at $7.83 million. Monitoring insider trading activity can provide insights into management's confidence in the company's prospects.

Approximately 42.47% of Aehr Test Systems is owned by public companies and individual investors. This indicates a significant retail investor base. A substantial retail ownership can sometimes lead to increased stock volatility, especially influenced by social media trends and online investment communities.

The ownership structure of Aehr Test Systems can impact its decision-making processes. Large institutional investors often exert influence on the company's management and can affect the company's stock price through their trading activities. Understanding these dynamics is crucial for investors. It's also important to consider the Breaking Down Aehr Test Systems (AEHR) Financial Health: Key Insights for Investors.

Here's a summary of the ownership composition:

Ownership Type Percentage
Institutional Investors 72%
Insiders 6.48%
Public Companies and Individual Investors 42.47%

The latest closing stock price for Aehr Test Systems as of April 15, 2025, was $8.54. The 52-week high stock price is $21.44, which is 151.1% above the current share price, while the 52-week low is $6.27, 26.6% below the current price. The average stock price for the last 52 weeks is $12.49.

Aehr Test Systems (AEHR) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions to Aehr Test Systems (AEHR) is crucial for assessing the company's stability and growth potential. Major shareholders' attitudes, significant ownership changes, and analyst perspectives all play vital roles in shaping the company's future.

Recent market reactions to Aehr Test Systems (AEHR) have been influenced by several factors, including earnings reports, industry trends, and overall market conditions. Monitoring these reactions provides insights into how the investment community views the company's prospects and its ability to execute its strategic initiatives.

Analyst perspectives offer valuable insights into the potential impact of key investors on Aehr Test Systems' future. These analysts often evaluate the company's financial performance, growth opportunities, and competitive landscape to provide recommendations and price targets. Their analysis can significantly influence investor sentiment and market behavior.

Institutional ownership in Aehr Test Systems represents a significant portion of the company's shares. As of December 31, 2024, institutional investors held 73.90% of Aehr Test Systems' outstanding shares. This indicates strong institutional interest and confidence in the company's long-term prospects.

Here are some of the major institutional shareholders and their positions:

  • BlackRock Fund Advisors: Holds 1,224,935 shares, representing 4.23% of the company.
  • Vanguard Total Stock Market Index Fund: Holds 1,148,843 shares, representing 3.96% of the company.
  • Dimensional Fund Advisors LP: Holds 1,025,139 shares, representing 3.54% of the company.
  • State Street Global Advisors: Holds 613,914 shares, representing 2.12% of the company.
  • Geode Capital Management LLC: Holds 524,897 shares, representing 1.81% of the company.

Changes in institutional ownership can signal shifts in sentiment. For example, an increase in holdings by a major institutional investor may indicate a positive outlook, while a decrease could suggest concerns about future performance. Recent transactions by institutional investors include:

  • BlackRock Fund Advisors increased its holdings by 3.2% in the first quarter of 2024.
  • Vanguard Total Stock Market Index Fund increased its holdings by 2.8% in the same period.
  • Dimensional Fund Advisors LP increased its holdings by 4.1% in the first quarter of 2024.

These changes reflect ongoing evaluations and adjustments to their investment strategies regarding Aehr Test Systems.

The table below summarizes key institutional ownership data for Aehr Test Systems:

Institutional Investor Shares Held Percentage of Company
BlackRock Fund Advisors 1,224,935 4.23%
Vanguard Total Stock Market Index Fund 1,148,843 3.96%
Dimensional Fund Advisors LP 1,025,139 3.54%
State Street Global Advisors 613,914 2.12%
Geode Capital Management LLC 524,897 1.81%

Understanding the history, ownership structure, mission, and business model of Aehr Test Systems can provide additional context for evaluating investor sentiment. More information can be found here: Aehr Test Systems (AEHR): History, Ownership, Mission, How It Works & Makes Money

DCF model

Aehr Test Systems (AEHR) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.